Form 4 holding
Director
BIOCRYST PHARMACEUTICALS INC
- Security class
- Common Stock
- Shares / value
- 100,198
- Estimated value
- $606,198
- Report date
- 28 Feb 2023
- Price
- $6.05
- Ownership
- Direct
Robert Alexander Ingram - Director at BIOCRYST PHARMACEUTICALS INC
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- BCRX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert Alexander Ingram since 28 Aug 2025
Reported holdings for Robert Alexander Ingram in BIOCRYST PHARMACEUTICALS INC
Transaction history for Robert Alexander Ingram in BIOCRYST PHARMACEUTICALS INC
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.